Bessemer Group’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
1
-100
| -99% | – | ﹤0.01% | 2657 |
|
|
2025
Q1 | $6K | Sell |
101
-399
| -80% | -$23.7K | ﹤0.01% | 1973 |
|
|
2024
Q4 | $31K | Buy |
+500
| New | +$31K | ﹤0.01% | 1379 |
|
|
2020
Q3 | – | Sell |
-13,200
| Closed | -$1.17M | – | 1678 |
|
|
2020
Q2 | $1.17M | Buy |
13,200
+300
| +2% | +$26.6K | ﹤0.01% | 697 |
|
|
2020
Q1 | $1.21M | Buy |
12,900
+300
| +2% | +$28.2K | ﹤0.01% | 552 |
|
|
2019
Q4 | $1.36M | Buy |
12,600
+200
| +2% | +$21.6K | ﹤0.01% | 680 |
|
|
2019
Q3 | $1.19M | Buy |
12,400
+200
| +2% | +$19.2K | ﹤0.01% | 656 |
|
|
2019
Q2 | $1.17M | Buy |
12,200
+400
| +3% | +$38.3K | ﹤0.01% | 674 |
|
|
2019
Q1 | $1.04M | Buy |
11,800
+3,000
| +34% | +$265K | ﹤0.01% | 622 |
|
|
2018
Q4 | $731K | Buy |
8,800
+1,500
| +21% | +$125K | ﹤0.01% | 650 |
|
|
2018
Q3 | $688K | Hold |
7,300
| – | – | ﹤0.01% | 677 |
|
|
2018
Q2 | $804K | Hold |
7,300
| – | – | ﹤0.01% | 628 |
|
|
2018
Q1 | $722K | Buy |
7,300
+100
| +1% | +$9.89K | ﹤0.01% | 664 |
|
|
2017
Q4 | $586K | Sell |
7,200
-500
| -6% | -$40.7K | ﹤0.01% | 766 |
|
|
2017
Q3 | $566K | Buy |
7,700
+3,100
| +67% | +$228K | ﹤0.01% | 814 |
|
|
2017
Q2 | $333K | Buy |
4,600
+1,300
| +39% | +$94.1K | ﹤0.01% | 951 |
|
|
2017
Q1 | $206K | Hold |
3,300
| – | – | ﹤0.01% | 1091 |
|
|
2016
Q4 | $240K | Buy |
3,300
+1,400
| +74% | +$102K | ﹤0.01% | 1050 |
|
|
2016
Q3 | $114K | Buy |
+1,900
| New | +$114K | ﹤0.01% | 1081 |
|